Loading clinical trials...
Loading clinical trials...
Safety Profile Assessment of TheraSphere® Yttrium-90 Glass Microspheres Used for Treatment of Hepatocellular Carcinoma: A Pilot Study
Conditions
Interventions
Selective internal radiation therapy of the liver with Yttrium-90 glass microspheres (TheraSphere)
Locations
1
United States
University of California San Francisco
San Francisco, California, United States
Start Date
May 1, 2010
Primary Completion Date
May 1, 2014
Completion Date
May 1, 2014
Last Updated
May 13, 2019
NCT05969860
NCT07164313
NCT06811116
NCT06066138
NCT07485114
NCT06345508
Lead Sponsor
University of California, San Francisco
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions